Skip to main content
TipRanks
Go Ultimate75% OFF

Conavi Medical (CNVIF) Stock Statistics & Valuation Metrics

512 Followers

Total Valuation

Conavi Medical has a market cap or net worth of $10.51M. The enterprise value is $39.89M.

Market Cap
$10.51M
Enterprise Value
$39.89M

Share Statistics

Conavi Medical has 119,857,994 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
119,857,994
Owned by Insiders
18.19%
Owned by Institutions
0.00%

Financial Efficiency

Conavi Medical’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
-5.83M
Employee Count
4
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, Conavi Medical had revenue of ― and earned -23.32M in profits. Earnings per share was ―.

Revenue
―
Gross Profit
―
Operating Income
-27.53M
Pretax Income
―
Net Income
-23.32M
EBITDA
-27.50M
Earnings Per Share (EPS)
―

Stock Price Statistics

Beta
0.78
52-Week Price Change
-80.14%
50-Day Moving Average
0.10
200-Day Moving Average
0.20
Relative Strength Index (RSI)
51.06
Average Volume (3m)
62.30K

Important Dates

Conavi Medical upcoming earnings date is Dec 17, 2026, TBA (Not Confirmed).

Last Earnings Date
Aug 27, 2026
Next Earnings Date
Dec 17, 2026
Ex-Dividend Date
―

Balance Sheet

Conavi Medical has ― in cash and marketable securities with $2.12M in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
$2.12M
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Analyst Forecast

The average price target for Conavi Medical is $0.92, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$0.92
Price Target Upside
971.13% Upside
Analyst Consensus
Moderate Buy
Analyst Count
1
Revenue Growth Forecast
―
EPS Growth Forecast
―